Cover Image

Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

Abstract The present study evaluated the safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor under development for the treatment of Alzheimer's disease (AD) in otherwise healthy young and elderly Chinese subjects. The study of young subjects...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hongjie Qian (Author), Chengyin Yu (Author), Huijuan Zhu (Author), Qichen Ding (Author), Yuting Cai (Author), Jiao Jing (Author), Xin Xu (Author), Runcong Guo (Author), Haiyan Zhang (Author), Hong Liu (Author), Xiaoyan Chen (Author), Yun Liu (Author)
Format:	Book
Published:	Wiley, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety, pharmacokinetics, and food effect of sudapyridine (WX‐081), a novel anti‐tuberculosis candidate in healthy Chinese subjects
by: Chengyin Yu, et al.
Published: (2024)

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers
by: Marie A. Printz, BA, et al.
Published: (2020)

Phase I Trial to Evaluate the Tolerance, Pharmacokinetics and Efficacy of the Broad-Spectrum ErbB Family Inhibitor Larotinib Mesylate in Patients With Advanced Solid Tumors
by: Jingrui Liu, et al.
Published: (2021)

Three to Tango: Inhibitory Effect of Quercetin and Apigenin on Acetylcholinesterase, Amyloid-β Aggregation and Acetylcholinesterase-Amyloid Interaction
by: Irene Álvarez-Berbel, et al.
Published: (2022)

Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers
by: Chan Zou, et al.
Published: (2019)

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
by: Yukio Ago, et al.
Published: (2011)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
by: Mohammad Al‐Mahdi Al‐Karagholi, et al.
Published: (2021)

A Phase I Clinical Study Comparing the Tolerance, Immunogenicity, and Pharmacokinetics of Proposed Biosimilar BAT1806 and Reference Tocilizumab in Healthy Chinese Men
by: Hong Zhang, et al.
Published: (2021)

A phase I, randomized study to evaluate the safety, tolerability, and pharmacokinetics of mefunidone in healthy subjects
by: Mai Han, et al.
Published: (2024)

Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers
by: Rui Zhu, et al.
Published: (2022)

HYPNOBIRTHING INCREASE PAIN TOLERANCE AND ANXIETY IN ACTIVE PHASE LABOR
by: Nursalam Nursalam, et al.
Published: (2017)

Advanced DC-DC Power Converters and Switching Converters
Published: (2021)

Anti-oxidant and anti-acetylcholinesterase activities of Zygophyllum album
by: Mouna Kchaou, et al.
Published: (2015)

Acetylcholinesterase Inhibitory Activity of Standardized Cannabinoids-rich Fractions
by: Wiwit Suttithumsatid, et al.
Published: (2023)

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
by: Shouyuan Sun, et al.
Published: (2022)

Investigating Acetylcholinesterase Inhibitory Effects of some Ferula Species
by: M Shekarchi, et al.
Published: (2013)

Acetylcholinesterase inhibitory effects of some plants from Rosaceae
by: S. Esmaeili, et al.
Published: (2015)

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease
by: Dajiang Zou, et al.
Published: (2023)

Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase Ⅰ study
by: Kai Huang, et al.
Published: (2022)

A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects
by: Qian Chen, et al.
Published: (2023)

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
by: Muñoz-Villegas P, et al.
Published: (2021)

DC Circuits
by: Davis, Chad
Published: (2016)

Safety, Tolerability, and Pharmacokinetics of Adrenomedullin in Healthy Males: A Randomized, Double-Blind, Phase 1 Clinical Trial
by: Kita T, et al.
Published: (2020)

Exploring the pharmacokinetics and tolerability of cyclooxygenase inhibitor ampiroxicam: a phase I study on single and multiple oral doses
by: Pengfei Zhao, et al.
Published: (2024)

A phase I, first‐in‐human study investigating the safety, tolerability, and pharmacokinetics of the maturation inhibitor GSK3739937
by: Paul D. Benn, et al.
Published: (2023)

Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants
by: Cheung TT, et al.
Published: (2023)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
by: Xue Zhao, et al.
Published: (2023)

A phase I study comparing the pharmacokinetics and safety of HS628 (tocilizumab biosimilar) and reference tocilizumab in healthy male subjects
by: Hongjie Qian, et al.
Published: (2023)

Structure-activity relationship investigation of benzamide and picolinamide derivatives containing dimethylamine side chain as acetylcholinesterase inhibitors
by: Xiao-hui Gao, et al.
Published: (2018)

Development of tacrine clusters as positively cooperative systems for the inhibition of acetylcholinesterase
by: Tereza Cristina Santos Evangelista, et al.
Published: (2021)

Evaluation of N-alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors
by: Kaitlyn N. Alcorn, et al.
Published: (2024)

Molecular interactions of an alkaloid euchrestifoline as a new acetylcholinesterase inhibitor
by: Fazal Ur Rehman, et al.
Published: (2013)

Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies
by: Huseyin Cavdar, et al.
Published: (2019)

Evaluating the antioxidant and acetylcholinesterase inhibitory activity of three Centaurea species
by: H. Hajimehdipoor, et al.
Published: (2014)

Isolation and characterization of acetylcholinesterase inhibitors from Piper longum L.
by: Z. Khatami*, et al.
Published: (2017)

Evaluating the acetylcholinesterase inhibitory activity of Ferulago angulata and Ferulago subvelutina
by: H. Hajimehdipoor, et al.
Published: (2014)

Expression of DC-SIGN and DC-SIGNRs in placentas of HIV-positive patients
by: Komala Pillay, et al.
Published: (2014)

Power strategy in DC/DC converters to increase efficiency of electrical stimulators
by: Pablo Aqueveque, et al.
Published: (2016)

Safety, tolerance, and pharmacokinetics of salvianolic acid B in healthy Chinese volunteers: A randomized, double-blind, placebo-controlled phase 1 clinical trial
by: Junlin Cheng, et al.
Published: (2023)

Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a tissue‐nonspecific alkaline phosphatase inhibitor
by: Sonomi Maruyama, et al.
Published: (2022)